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Abstract
Background: Metastatic cancer is incurable and understanding the molecular underpinnings is crucial to improving
survival for our patients. The IGF-1/Akt signaling pathway is often impaired in cancer leading to its progression and
metastases. Diet modification is known to alter the IGF-1/Akt pathway and affect the expression of microRNA involved
in tumor initiation, growth and metastases. Liver metastases are one of the most common type of metastases in breast
and colon cancer. In the present study, we looked at the effect of diet modification on the expression of microRNA in
normal liver and liver with breast cancer metastases using in vivo model.
Methodology: 6-month-old C57BL/6 J mice were put on either an ad libitum (AL) diet, or 40% calorie restricted (CR)
diet or were fasted for 24 h (FA) before sacrifice. MicroRNA array analysis, western blot and qRT-PCR were performed
using liver tissue to compare the treatment groups. A breast cancer model was also used to study the changes in
microRNA expression in liver of a group of BALB/c mice orthotopically injected with 4 T1 cells in the mammary fat pad,
put on either an AL or 30% CR diet. Liver and primary tumor tissues were used to perform qRT-PCR to compare the
treatment groups.
Results: MicroRNA array analysis showed significant changes in miRNA expression in both CR and FA conditions in
normal liver. Expression of miR-29 and miR-30 family members was increased in both CR and FA. Western blot analysis
of the normal liver tissue showed that CR and FA downregulated the IGF-1/Akt pathway and qRT-PCR showed that the
expression of miR-29b, miR-29c, miR-30a and miR-30b were increased with CR and FA. Liver tissue collected from mice
in the breast cancer model showed an increase in expression of miR-29b, miR-29c and miR-30b while tumor tissue
showed increased expression of miR-29c, miR-30a and miR-30b.
Discussion: Members of the miR-29 family are known to target and suppress IGF-1, while members of the miR-30
family are known to target and suppress both IGF-1 and IGF-1R. In the present study, we observe that calorie restriction
increased the expression of miR-29 and miR-30 in both the normal liver as well as the liver with breast
cancer metastases. These findings suggest that dietary alterations may play a role in the treatment of liver
metastasis, which should be evaluated further.
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Introduction
Metastatic cancer is associated with disease that has
spread beyond its initial site requiring constant treatment
to prevent disease progression. Patients will ultimately
succumb to metastatic breast cancer from either conse-
quences of the disease or toxicity of treatment including
cardiac toxicities and secondary malignancies. Liver me-
tastases are among the most common types of metastases,
representing more than 50% of breast and colorectal me-
tastases, and are inescapably fatal [1, 2]. Few treatments
exist to restrain these metastases, emphasizing the import-
ance of identifying the novel molecular mechanisms driv-
ing them. The liver is a critical nutrient sensor and is rich
in metabolic processes affected by dietary alterations eval-
uated in prior works [3–5], but has not yet been examined
in the context of metastatic cancer. Caloric restriction
(CR) has previously been shown to play a role in decreas-
ing both primary tumor growth and metastases [6], and
short-term or intermittent fasting have been shown to re-
produce many of the physiologic changes observed during
CR, such as slowing tumor growth and incidence [7–9]. It
therefore follows that dietary alterations may play a role in
managing liver metastases.
At the mechanistic level, microRNAs (miRNA), or
small non-coding RNAs, play a role in cancer initiation,
progression and metastases [10–14] and are altered by
dietary interventions like fasting and caloric restriction
[15–18]. In the present study, we used in vivo experi-
ments to determine if dietary alterations affect miRNA
expression in the normal liver or in liver metastases
from breast cancer to identify potential novel targets for
breast cancer liver metastases. We report global micro-
RNA expression changes in liver tissue from normal
mice fed ad libitum (AL), 40% CR diet, or following a
24-h fast. Here we show increased expression of miR-29
and miR-30 family members due to these dietary inter-
ventions in the normal liver and breast cancer liver me-
tastases models. Multiple members of each of the
miRNA family directly target and repress the IGF-1/
IGF-1R signaling axis, which is associated with decreased
cancer progression and metastases. Our findings support
the use of dietary intervention in treatment and provide
a novel targeting strategy for therapies in the future.
Materials and methods
Mice and dietary regimen
For the normal mice subjected to ad libitum (AL) feed-
ing or dietary alterations, 15 6-month old C57BL/6 J
mice were obtained through the National Institute of
Aging (NIA) Aged Rodent Program under two feeding
conditions (Charles River) on an Institutional Animal
Care and Use Committee (IACUC) approved mouse
protocol. One group of 10 mice was fed AL diet, and the
remaining 5 mice were fed a calorie restriction (CR) diet
of 60% normal intake. CR was initiated a week after ar-
rival with a 10% restriction, increased to 25% restriction
the next week, and to 40% restriction the following
week, where it was maintained throughout the life of the
animal. All mice were singly housed throughout the ex-
periment and were fed NIH-31 food fortified with an
NIA supplement for CR mice. Age-matched AL mice
were fasted for 24 h (FA) before sacrifice.
To assess the effect of diet in a murine breast cancer
model, 12-week-old BALB/c mice were acquired from
Charles River Laboratories under an IACUC approved
protocol at Thomas Jefferson University. At 13 weeks, all
mice received orthotopic injections of 50,000 4T1
luciferase-tagged cells (a gift from Patricia Steeg) into the
#4 mammary fat pad. Mice treated with CR were stepped
down to 90% of their baseline chow intake for 5 days,
followed by 2 successive 10% decreases every 5 days until
a 30% total reduction was achieved (LabDiet 5010).
Total RNA purification, array analysis, and real-time PCR
AL, CR, and fasted mice were sacrificed; the liver tissues
were dissected and immediately placed in RNAlater
(Ambion). RNA was isolated from the liver tissue using
Trizol (Invitrogen) method. RNA concentration and qual-
ity were determined using Nanodrop and quantitative
real-time PCR (qRT-PCR) was performed (Applied Bio-
systems 7500 fast) using the miScript SYBR Green PCR
kit and miScript Primer Assay for miR-29 and miR-30
(Qiagen). miRNA levels were normalized to snord68 as an
internal control. miRNA microarray analysis was per-
formed by LC Sciences (Houston, TX) on 5 μg of total
RNA as previously described [19].
Immunoblotting
Total protein was extracted from 50mg of RNA-later pre-
served mouse liver tissue. Tissue was added to 1mL of
SDS lysis buffer (1% SDS, 50mM Tris pH 8.0, 10mM
EDTA, Protease inhibiter (Roche), and Halt Phosphatase
Inhibitor (Thermo Scientific) in a lysing matrix D tube
(MP Biomedicals). Tissue was homogenized using manu-
facturer’s suggested settings for a FastPrep-24 machine
(MP Biomedicals). Samples were sonicated using a probe
sonicator four times for 5 s each on ice and heated at
70 °C for 30min with mixing. Lysates were cleared by cen-
trifugation at 14,000 x g for 10min at 4 °C. Protein
concentration was determined using the BCA Protein
Assay (Thermo Scientific). 40 μg of total protein was sub-
jected to SDS-PAGE on a 4–12% gradient Bis-Tris gel
(Invitrogen). Protein was transferred to a 0.2-μm PVDF
membrane using the XCell transfer system (Invitrogen).
Western blots were performed using the following anti-
bodies: IGF-1 (Santa Cruz Biotechnology), IGF-1Rß (Cell
Signaling Technology), phospho-IGF-1R tyrosine 1165/
tyrosine 1166 (Sigma), IRS1 (Cell Signaling Technology),
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pan AKT (Cell Signaling Technology), phospho-AKT
serine 473(Cell Signaling Technology), GAPDH (Santa
Cruz Biotechnology).
Bioinformatics and statistics
miRNA arrays were performed on 3 samples for each con-
dition. Significance between normalized expressions from
array samples was determined using Student’s t-test and
p < 0.02. Data from the microarray experiments were col-
lected and analyzed in accordance with the MIAME
guidelines. MicroRNA expression profiles were analyzed
using IPA software 9 core analysis function and micro-
RNA target filter. miRNA target prediction was performed
using Targetscan 5.1 and PICTAR. Unless otherwise
stated, data represent the mean of 3 experiments, and
error bars represent standard error of mean.
Results
Array analysis of miRNA changes during caloric restriction
and fasting in mice
We detected global changes in miRNA expression
using liver tissue from age-matched C57BL/6 J mice
fed ad libitum (AL), 40% calorically restricted (CR),
or 24 h fasted (FA) mice analyzed by miRNA arrays.
These arrays show significant alterations in miRNA
expression (Fig. 1a-b) as well as a 73% overlap be-
tween CR and FA in the miRNAs changed (Fig. 1c).
Multiple microRNAs belonging to the highly con-
served miR-29 and miR-30 families showed signifi-
cantly increased expression after exposure to both
dietary interventions.
In order to analyze the effect of miRNAs with al-
tered expression in both conditions we used Ingenuity
Pathway analysis (IPA) software’s miRNA target filter
to identify experimentally observed targets reported in
the literature. This list was filtered for miRNAs with
detectable expression in mouse liver tissue in pub-
lished arrays [20, 21]. Core IPA analysis of the target
list revealed that one of the top networks altered in-
volved cell growth and proliferation centered on IGF-
1, EGF, and HGF growth factor signaling (Supplemen-
tary Figure 1). This is significant since many of the
cancer prevention effects of CR are thought to involve
repression of the pro-proliferation anti-apoptotic IGF-
1/AKT/mTOR signaling axis [22, 23].
CR increased expression of miR-29 and miR-30 family
members and altered IGF-1 signaling in normal liver
The microRNA prediction algorithm TargetScan v6.0
and IPA’s miRNA target filter were utilized to identify
predicted targets of the 26 microRNAs altered in both
fasting and CR, yielding > 58,000 predicted targets. To
focus this search, we filtered this gene list for targets of
miR-29 and miR-30 families that are known to be in-
volved in IGF-1 signaling.
miR-29 represses p85 (PIK3R1) [24] and miR-30 tar-
gets JUN [25], both of which are important in cancer
progression. We confirmed that multiple members of
the IGF-1 signaling cascade, including pro-IGF-1, IGF-
1R, IRS1, and phospho-Akt, are reduced in CR liver tis-
sue (Fig. 2a). In CR and fasted tissue, IGF-1 and IGF-1R
were reduced inversely to miR29 and miR-30 expression
as validated by qRT-PCR (Fig. 2a, b and c).
CR increases miR-29 and miR-30 expression in primary
breast tumor and liver tissue with metastases
We assessed miR-29 and miR-30 expression in the pri-
mary breast tumor and liver tissue with breast cancer
metastases of BALB/c mice fed AL or 30% reduced CR
diets, to determine if CR effects the expression of these
miRNAs. qRT-PCR was performed to survey miR-29
and miR-30 family member expression.CR increased
miR-29b in the liver tissue by 2.5-fold compared to AL
(Fig. 2e(i)) with no change in expression in the tumor
(Fig. 2d(i)). CR also increased the expression of miR-29c
in the tumor and liver tissue by ~ 3.4-fold and ~ 9-fold
respectively (Fig. 2d (ii) and Fig. 2e (ii)). CR caused a
3.5-fold increase in the expression of miR-30a in tumor
(Fig. 2d (iii)) and a 5-fold and 4-fold increase in miR-30b
expression in tumor and liver tissue respectively (Fig. 2d
(iv) and 2E (iv)).
Discussion
Our initial hypothesis that microRNAs play a functional
role in mediating the physiological effects of dietary re-
striction is supported by our observation of the changes
in the unique global expression patterns of liver micro-
RNAs of calorically restricted (− 40%) or 24-h fasted
C57BL/6 J mice compared to AL controls. It must also
be noted that fasting produces > 2 fold more alterations
to microRNA expression than CR (71 vs. 38). We pre-
dict that the larger group of miRNAs altered by fasting
is due to an acute response, while expression changes
(See figure on previous page.)
Fig. 1 Diet modification changes the expressions of multiple microRNA in normal liver tissue of mice. MicroRNA expression patterns were detected by
microarray from total RNA purified from normal liver tissue of C57BL/6 J mice following Ad. Libitum (AL) diet, 40% Caloric restriction (CR) diet or a 24-h
fast (FA). a Heat map clustering of significantly changed microRNAs in normal livers of mice on AL or FA diet. b Heat map clustering of significantly
changed microRNAs in normal livers of mice on AL or CR diet. c Venn diagram showing liver microRNA expression overlap between CR and FA
diet groups
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detected in the CR group represent stable changes due
to longer-term dietary changes. However, 73% of the
miRNA expression changes that were detected in the CR
group were also altered in the fasted group, suggesting
that they may be mechanistically important in pathways
influenced by dietary alterations.
Systems analysis of experimentally reported targets of
the group of miRNAs that were changed in both condi-
tions using IPA software showed an enrichment in tran-
scripts that, if repressed, would suppress several growth
factor signaling pathways. This observation is in agree-
ment with what is known in general about the cellular
response to dietary restriction, whereby growth and
reproduction is repressed in favor of maintenance and
repair [26]. Expression of several family members of the
miR-29 and miR-30 family was increased in both the
fasted and CR tissues; and are associated with tumor
suppressive processes. Specifically, the miR-29 family
plays an inhibitory role in oncogenic metabolism affect-
ing proliferation, angiogenesis, metastasis, and apoptosis.
miR-29 has been shown to be tumor suppressive in
more than 95% publications based on cancer studies
[27]. Overexpression of miR-29a directly suppressed
IGF-1R in the HepG2 Hepatocellular Carcinoma cell-
line [28]. Park et al. in an in vitro study showed that
members of the miR-29 family repressed p85α (PI3K)
and upregulated p53 [24]. miR-30 family members act as
both tumor suppressive and oncogenic miRNAs depend-
ing on the type of cancer. As a tumor suppressor in
breast cancer, gastric cancer, pancreatic cancer and renal
cell carcinoma, miR-30 prevents proliferation, invasion
and metastasis [29–32] by targeting IGF-1R [31].
Many primary tumors spread to the liver, with greater
than 50% of colorectal tumors metastasizing to the liver
[2]. Other more common cancers that produce liver me-
tastases include breast cancer, lung cancer and pancre-
atic cancer among others [32]. Since the members of the
miR-29 and miR-30 family repress the IGF-1 signaling
pathway, we explored the capacity of diet to alter meta-
static tumor biology. CR increased the expression of
miR-29b, miR-30a and miR-30b in the tumor, and in-
creased expression of miR-29b, miR-29c and miR-30b in
the liver tissue with metastases from breast tumor. We
believe that alterations to miR-30a expression in primary
breast cancers not observed in the liver are due to
differences in the two environments that drive different
expression pathways leading to miR-30 family expres-
sion. Here we show that CR leads to increased expres-
sion of miR-29 and miR-30 in the both the normal liver,
primary breast tumor and liver with metastases from
BC. Both these microRNAs repress IGF-1, while IGF-1R
was a target of miR-30 alone. These findings are in
agreement with our previous studies in an in vivo
model of triple negative breast cancer (TNBC) that
showed that at both the mRNA and protein level
these genes are downregulated by CR alone or in
combination with other treatments [6, 33]. Diet
modification has also been shown to downregulate
the IGF-1 signaling in other cancers including pros-
tate, pancreatic and colon cancer thereby delaying
their progression [34–36]. Many studies have dem-
onstrated the role of IGF-1/ IGF-1R signaling path-
way in invasion and metastasis [37–39].
The liver produces 90% of all IGF-1 and we observe
that CR represses IGF-1 and IGF-1R via regulation by
miR-29 and miR-30. Taken together we hypothesize that
CR combined with other treatment may be able to pre-
vent progression of liver metastasis via the upregulation
of miR-29 and miR-30 and downregulation of the IGF-
1/AKT/mTOR signaling pathway. Using a dietary inter-
vention to downregulate the IGF-1 pathway could repre-
sent an ideal strategy to employ in clinical practice since
the downregulation of this pathway is known to decrease
cancer progression and metastases.
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